Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Sumitomo Dainippon Pharma Co., Ltd.
483
•Sumitomo Dainippon Pharma Co., Ltd.•August 7, 2025

Sumitomo Dainippon Pharma Co., Ltd. – FDA 483, Aug 7, 2025

Record Details

An FDA inspection was conducted at Suzuka Plant from August 3 to August 7, 2025, revealing several observations documented in an FDA Form 483. These observations indicate deficiencies in the firm's adherence to Good Manufacturing Practices for drug products, necessitating prompt corrective actions.

Key issues identified include inadequate sampling procedures for incoming raw materials and excipients. The firm consistently sampled only four containers per lot, regardless of the total quantity received, without documented scientific justification, compromising the representativeness of samples.

Additionally, the inspection noted a failure to establish and follow procedures for preventing objectionable microorganisms in non-sterile drug products. A critical system, utilized in drug product manufacturing and equipment cleaning, lacked evaluation for microbial absence, and no documented microbial risk assessment was performed to ensure an adequate control strategy.

Furthermore, the firm failed to maintain complete backup files for electronic data. A visual inspection instrument, crucial for detecting tablet defects, was not configured to save or transfer electronic data to retrievable storage, hindering subsequent review, verification, or audit processes.

These observations highlight critical areas where the firm must implement comprehensive corrective and preventive measures to ensure product quality, safety, and regulatory compliance.

Company
Sumitomo Dainippon Pharma Co., Ltd.
Inspection date
August 7, 2025
Product type
drugs
Office
Office of Compliance and Biologics Quality
Person
  • Tekalign Wondimu ( Drug Investigator)
View Company Profile

ID · 86bec48e-adb4-4655-bc52-1a8046463dde

Other documents for Sumitomo Dainippon Pharma Co., Ltd.
  • 483 - 2019-11-22November 22, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sumitomo Dainippon Pharma Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.